2345
|
AZ 20
|
Potent, orally active and selective inhibitor of ATR protein kinase |
€105.00 |
2342
|
AZD9291
|
Potent oral, irreversible, third-generation EGFR TKI with selectivity for mutant EGFRs |
€95.00 |
2353
|
Blonanserin
|
Potent dopamine D2 and serotonin 5-HT2 antagonist |
€65.00 |
2184
|
CID 1067700
|
First inhibitor of Rab7 GTPase |
€125.00 |
2286
|
Evacetrapib
|
Potent, and selective inhibitor of CETP |
€125.00 |
2355
|
FPH 2
|
Proliferation inducer of mature human primary hepatocytes |
€110.00 |
2361
|
JNK-IN-8
|
Remarkably potent and selective covalent inhibitor of JNK |
€95.00 |
2349
|
JSH 23
|
Inhibitor of NF-κB transcription and nuclear translocation of p65 without affecting IκBα degradation |
€95.00 |
2357
|
LXR 623
|
Partial agonist of Liver X Receptor |
€95.00 |
2358
|
Mps1-IN-2
|
Inhibitor of Mps1 kinase with add-on affinity for Gak and Plk1 |
€95.00 |
2327
|
NEO 212
|
DNA alkylating agent; chemotherapeutic |
€110.00 |
1856
|
PU-H71 trihydrochloride
|
Hsp90 inhibitor |
€105.00 |
2352
|
Roflumilast
|
First specific PDE4 inhibitor licensed for treatment of COPD |
€90.00 |
2344
|
TM 5275
|
Selective and orally active inhibitor of PAI-1 |
€105.00 |
2346
|
UNC2250
|
Potent Mer kinase inhibitor with promising selectivity and PK properties. |
€80.00 |
2316
|
WP 1066
|
Potent JAK2 and STAT3 inhibitor and downregulator of antiapoptotic proteins |
€95.00 |